Lingling Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lingling Shi has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Li Zhang
Key Laboratory of CNS Regeneration (Ministry of Education), Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China
4 shared publications Xiaoxia Chen
Guangdong-Hongkong-Macau CNS Regeneration Institute of Jinan University, Key Laboratory of CNS Regeneration (Jinan University)-Ministry of Education, Guangdong Key Laboratory of Non-human Primate Research, Guangzhou, China
4 shared publicationsYimei Niu
Key Laboratory of CNS Regeneration (Ministry of Education), Guangdong Key Laboratory of Non-human Primate Research, GHM Institute of CNS Regeneration, Jinan University, Guangzhou, Guangdong 510632, China
4 shared publicationsHongyao Zhu
Key Laboratory of CNS Regeneration (Ministry of Education), Guangdong Key Laboratory of Non-human Primate Research, GHM Institute of CNS Regeneration, Jinan University, Guangzhou, Guangdong 510632, China
3 shared publicationsKwok-Fai So
Key Laboratory of CNS Regeneration (Ministry of Education), Guangdong Key Laboratory of Non-human Primate Research, GHM Institute of CNS Regeneration, Jinan University, Guangzhou, Guangdong 510632, China
3 shared publications- Kwok-Fai So
Jinan University
3 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by Elsevier in Acta Psychologica
- Vol. 264, 106492
The effectiveness and feasibility of the new Forest parenting programme for Chinese children with attention-deficit/hyperactivity disorder and their families
- 26 February 2026
- Published by Elsevier in Acta Psychologica
- Vol. 264, 106492
Open AccessThe effectiveness and feasibility of the new Forest parenting programme for Chinese children with attention-deficit/hyperactivity disorder and their families
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (1)
iceDP: identifying inter-chromatin engagement via density peaks clustering algorithm
Chromatin topological structure is critical for gene regulation. Hi-C based experiments have significantly advanced our understanding chromatin organization. Numerous computational tools have been developed to identify various structural levels of chromatin, ranging from compartments to loops. However, there remains a lack of specialized tools for identifying non-homologous inter-chromatin contacts (NHCCs), which play important roles in chromosome territories. In this study, we present iceDP, a tool that leverages the Density Peaks clustering algorithm to identify local high-density regions within inter-chromatin. These regions undergo two subsequent filtering steps to eliminate obvious false positives. When applied to three Hi-C datasets, iceDP accurately identified known NHCCs, including olfactory receptor genes in mature olfactory sensory neurons and Polycomb repressive complex-regulated developmental genes in mouse embryonic stem cells (mESCs). Notably, iceDP also uncovered previously unreported transcriptionally active NHCCs. Compared to diffHiC and FitHiC, iceDP exhibited superior performance with the highest positive rate. Moreover, iceDP is compatible with a wide range of chromatin conformation capture techniques, including in-situ Hi-C, Micro-C, HiChIP, and BL-HiC, demonstrating its versatility and utility.
- 7 January 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (1)
Open AccessiceDP: identifying inter-chromatin engagement via density peaks clustering algorithm
Chromatin topological structure is critical for gene regulation. Hi-C based experiments have significantly advanced our understanding chromatin organization. Numerous computational tools have been developed to identify various structural levels of chromatin, ranging from compartments to loops. However, there remains a lack of specialized tools for identifying non-homologous inter-chromatin contacts (NHCCs), which play important roles in chromosome territories. In this study, we present iceDP, a tool that leverages the Density Peaks clustering algorithm to identify local high-density regions within inter-chromatin. These regions undergo two subsequent filtering steps to eliminate obvious false positives. When applied to three Hi-C datasets, iceDP accurately identified known NHCCs, including olfactory receptor genes in mature olfactory sensory neurons and Polycomb repressive complex-regulated developmental genes in mouse embryonic stem cells (mESCs). Notably, iceDP also uncovered previously unreported transcriptionally active NHCCs. Compared to diffHiC and FitHiC, iceDP exhibited superior performance with the highest positive rate. Moreover, iceDP is compatible with a wide range of chromatin conformation capture techniques, including in-situ Hi-C, Micro-C, HiChIP, and BL-HiC, demonstrating its versatility and utility.
- Open Access
- 16 July 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116012
The knockout of Moesin leads to excess microglia-mediated synaptic pruning and impairs social novelty in a mouse model
- 16 July 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (8) , 116012
Open AccessThe knockout of Moesin leads to excess microglia-mediated synaptic pruning and impairs social novelty in a mouse model
- 15 December 2024
- Published by Elsevier in Biomaterials
- Vol. 316, 123011
Selenium promotes neural development through the regulation of GPX4 and SEPP1 in an iPSC-derived neuronal model
- 15 December 2024
- Published by Elsevier in Biomaterials
- Vol. 316, 123011
Selenium promotes neural development through the regulation of GPX4 and SEPP1 in an iPSC-derived neuronal model
- Open Access
- 4 May 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (10) , 3180-3194
Autism patient-derived SHANK2BY29X mutation affects the development of ALDH1A1 negative dopamine neuron
Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental conditions. Different mutations on a single ASD gene contribute to heterogeneity of disease phenotypes, possibly due to functional diversity of generated isoforms. SHANK2, a causative gene in ASD, demonstrates this phenomenon, but there is a scarcity of tools for studying endogenous SHANK2 proteins in an isoform-specific manner. Here, we report a point mutation on SHANK2, which is found in a patient with autism, located on exon of the SHANK2B transcript variant (NM_133266.5), hereby SHANK2BY29X. This mutation results in an early stop codon and an aberrant splicing event that impacts SHANK2 transcript variants distinctly. Induced pluripotent stem cells (iPSCs) carrying this mutation, from the patient or isogenic editing, fail to differentiate into functional dopamine (DA) neurons, which can be rescued by genetic correction. Available SMART-Seq single-cell data from human midbrain reveals the abundance of SHANK2B transcript in the ALDH1A1 negative DA neurons. We then show that SHANK2BY29X mutation primarily affects SHANK2B expression and ALDH1A1 negative DA neurons in vitro during early neuronal developmental stage. Mice knocked in with the identical mutation exhibit autistic-like behavior, decreased occupancy of ALDH1A1 negative DA neurons and decreased dopamine release in ventral tegmental area (VTA). Our study provides novel insights on a SHANK2 mutation derived from autism patient and highlights SHANK2B significance in ALDH1A1 negative DA neuron.
- 4 May 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (10) , 3180-3194
Open AccessAutism patient-derived SHANK2BY29X mutation affects the development of ALDH1A1 negative dopamine neuron
Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental conditions. Different mutations on a single ASD gene contribute to heterogeneity of disease phenotypes, possibly due to functional diversity of generated isoforms. SHANK2, a causative gene in ASD, demonstrates this phenomenon, but there is a scarcity of tools for studying endogenous SHANK2 proteins in an isoform-specific manner. Here, we report a point mutation on SHANK2, which is found in a patient with autism, located on exon of the SHANK2B transcript variant (NM_133266.5), hereby SHANK2BY29X. This mutation results in an early stop codon and an aberrant splicing event that impacts SHANK2 transcript variants distinctly. Induced pluripotent stem cells (iPSCs) carrying this mutation, from the patient or isogenic editing, fail to differentiate into functional dopamine (DA) neurons, which can be rescued by genetic correction. Available SMART-Seq single-cell data from human midbrain reveals the abundance of SHANK2B transcript in the ALDH1A1 negative DA neurons. We then show that SHANK2BY29X mutation primarily affects SHANK2B expression and ALDH1A1 negative DA neurons in vitro during early neuronal developmental stage. Mice knocked in with the identical mutation exhibit autistic-like behavior, decreased occupancy of ALDH1A1 negative DA neurons and decreased dopamine release in ventral tegmental area (VTA). Our study provides novel insights on a SHANK2 mutation derived from autism patient and highlights SHANK2B significance in ALDH1A1 negative DA neuron.
- Top Cited PapersOpen Access
- 8 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Stress increases hepatic release of lipocalin 2 which contributes to anxiety-like behavior in mice
Chronic stress induces anxiety disorders via both neural pathways and circulating factors. Although many studies have elucidated the neural circuits involved in stress-coping behaviors, the origin and regulatory mechanism of peripheral cytokines in behavioural regulation under stress conditions are not fully understood. Here, we identified a serum cytokine, lipocalin 2 (LCN2), that was upregulated in participants with anxiety disorders. Using a mouse model of chronic restraint stress (CRS), circulating LCN2 was found to be related to stress-induced anxiety-like behaviour via modulation of neural activity in the medial prefrontal cortex (mPFC). These results suggest that stress increases hepatic LCN2 via a neural pathway, leading to disrupted cortical functions and behaviour.
- 8 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Top Cited PapersOpen AccessStress increases hepatic release of lipocalin 2 which contributes to anxiety-like behavior in mice
Chronic stress induces anxiety disorders via both neural pathways and circulating factors. Although many studies have elucidated the neural circuits involved in stress-coping behaviors, the origin and regulatory mechanism of peripheral cytokines in behavioural regulation under stress conditions are not fully understood. Here, we identified a serum cytokine, lipocalin 2 (LCN2), that was upregulated in participants with anxiety disorders. Using a mouse model of chronic restraint stress (CRS), circulating LCN2 was found to be related to stress-induced anxiety-like behaviour via modulation of neural activity in the medial prefrontal cortex (mPFC). These results suggest that stress increases hepatic LCN2 via a neural pathway, leading to disrupted cortical functions and behaviour.
- Open Access
- 4 September 2023
- Published by Medknow in Neural Regeneration Research
- Vol. 19 (4) , 908-914
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons
JOURNAL/nrgr/04.03/01300535-202404000-00037/inline-graphic1/v/2023-09-09T133047Z/r/image-tiff Midbrain dopaminergic neurons play an important role in the etiology of neurodevelopmental and neurodegenerative diseases. They also represent a potential source of transplanted cells for therapeutic applications. In vitro differentiation of functional midbrain dopaminergic neurons provides an accessible platform to study midbrain neuronal dysfunction and can be used to examine obstacles to dopaminergic neuronal development. Emerging evidence and impressive advances in human induced pluripotent stem cells, with tuned neural induction and differentiation protocols, makes the production of induced pluripotent stem cell-derived dopaminergic neurons feasible. Using SB431542 and dorsomorphin dual inhibitor in an induced pluripotent stem cell-derived neural induction protocol, we obtained multiple subtypes of neurons, including 20% tyrosine hydroxylase-positive dopaminergic neurons. To obtain more dopaminergic neurons, we next added sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8) on day 8 of induction. This increased the proportion of dopaminergic neurons, up to 75% tyrosine hydroxylase-positive neurons, with 15% tyrosine hydroxylase and forkhead box protein A2 (FOXA2) co-expressing neurons. We further optimized the induction protocol by applying the small molecule inhibitor, CHIR99021 (CHIR). This helped facilitate the generation of midbrain dopaminergic neurons, and we obtained 31–74% midbrain dopaminergic neurons based on tyrosine hydroxylase and FOXA2 staining. Thus, we have established three induction protocols for dopaminergic neurons. Based on tyrosine hydroxylase and FOXA2 immunostaining analysis, the CHIR, SHH, and FGF8 combined protocol produces a much higher proportion of midbrain dopaminergic neurons, which could be an ideal resource for tackling midbrain-related diseases.
- 4 September 2023
- Published by Medknow in Neural Regeneration Research
- Vol. 19 (4) , 908-914
Open AccessMultiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons
JOURNAL/nrgr/04.03/01300535-202404000-00037/inline-graphic1/v/2023-09-09T133047Z/r/image-tiff Midbrain dopaminergic neurons play an important role in the etiology of neurodevelopmental and neurodegenerative diseases. They also represent a potential source of transplanted cells for therapeutic applications. In vitro differentiation of functional midbrain dopaminergic neurons provides an accessible platform to study midbrain neuronal dysfunction and can be used to examine obstacles to dopaminergic neuronal development. Emerging evidence and impressive advances in human induced pluripotent stem cells, with tuned neural induction and differentiation protocols, makes the production of induced pluripotent stem cell-derived dopaminergic neurons feasible. Using SB431542 and dorsomorphin dual inhibitor in an induced pluripotent stem cell-derived neural induction protocol, we obtained multiple subtypes of neurons, including 20% tyrosine hydroxylase-positive dopaminergic neurons. To obtain more dopaminergic neurons, we next added sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8) on day 8 of induction. This increased the proportion of dopaminergic neurons, up to 75% tyrosine hydroxylase-positive neurons, with 15% tyrosine hydroxylase and forkhead box protein A2 (FOXA2) co-expressing neurons. We further optimized the induction protocol by applying the small molecule inhibitor, CHIR99021 (CHIR). This helped facilitate the generation of midbrain dopaminergic neurons, and we obtained 31–74% midbrain dopaminergic neurons based on tyrosine hydroxylase and FOXA2 staining. Thus, we have established three induction protocols for dopaminergic neurons. Based on tyrosine hydroxylase and FOXA2 immunostaining analysis, the CHIR, SHH, and FGF8 combined protocol produces a much higher proportion of midbrain dopaminergic neurons, which could be an ideal resource for tackling midbrain-related diseases.
- 17 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (7) , eadd5330
A gut-brain axis mediates sodium appetite via gastrointestinal peptide regulation on a medulla-hypothalamic circuit
Salt homeostasis is orchestrated by both neural circuits and peripheral endocrine factors. The colon is one of the primary sites for electrolyte absorption, while its potential role in modulating sodium intake remains unclear. Here, we revealed that a gastrointestinal hormone, secretin, is released from colon endocrine cells under body sodium deficiency and is indispensable for inducing salt appetite. As the neural substrate, circulating secretin activates specific receptors in the nucleus of the solitary tracts, which further activates the downstream paraventricular nucleus of the hypothalamus, resulting in enhanced sodium intake. These results demonstrated a previously unrecognized gut-brain pathway for the timely regulation of sodium homeostasis.
- 17 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (7) , eadd5330
A gut-brain axis mediates sodium appetite via gastrointestinal peptide regulation on a medulla-hypothalamic circuit
Salt homeostasis is orchestrated by both neural circuits and peripheral endocrine factors. The colon is one of the primary sites for electrolyte absorption, while its potential role in modulating sodium intake remains unclear. Here, we revealed that a gastrointestinal hormone, secretin, is released from colon endocrine cells under body sodium deficiency and is indispensable for inducing salt appetite. As the neural substrate, circulating secretin activates specific receptors in the nucleus of the solitary tracts, which further activates the downstream paraventricular nucleus of the hypothalamus, resulting in enhanced sodium intake. These results demonstrated a previously unrecognized gut-brain pathway for the timely regulation of sodium homeostasis.
- Open Access
- 1 September 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 735, 135201
Transplantation of human urine-derived neural progenitor cells after spinal cord injury in rats
- 1 September 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 735, 135201
Open AccessTransplantation of human urine-derived neural progenitor cells after spinal cord injury in rats
- Open Access
- 19 June 2020
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 15 (12) , 2335-2343
Insulin-like growth factor 1 partially rescues early developmental defects caused by SHANK2 knockdown in human neurons
SHANK2 is a scaffold protein that serves as a protein anchor at the postsynaptic density in neurons. Genetic variants of SHANK2 are strongly associated with synaptic dysfunction and the pathophysiology of autism spectrum disorder. Recent studies indicate that early neuronal developmental defects play a role in the pathogenesis of autism spectrum disorder, and that insulin-like growth factor 1 has a positive effect on neurite development. To investigate the effects of SHANK2 knockdown on early neuronal development, we generated a sparse culture system using human induced pluripotent stem cells, which then differentiated into neural progenitor cells after 3–14 days in culture, and which were dissociated into single neurons. Neurons in the experimental group were infected with shSHANK2 lentivirus carrying a red fluorescent protein reporter (shSHANK2 group). Control neurons were infected with scrambled shControl lentivirus carrying a red fluorescent protein reporter (shControl group). Neuronal somata and neurites were reconstructed based on the lentiviral red fluorescent protein signal. Developmental dendritic and motility changes in VGLUT1 + glutamatergic neurons and TH + dopaminergic neurons were then evaluated in both groups. Compared with shControl VGLUT1 + neurons, the dendritic length and arborizations of shSHANK2 VGLUT1 + neurons were shorter and fewer, while cell soma speed was higher. Furthermore, dendritic length and arborization were significantly increased after insulin-like growth factor 1 treatment of shSHANK2 neurons, while cell soma speed remained unaffected. These results suggest that insulin-like growth factor 1 can rescue morphological defects, but not the change in neuronal motility. Collectively, our findings demonstrate that SHANK2 deficiency perturbs early neuronal development, and that IGF1 can partially rescue the neuronal defects caused by SHANK2 knockdown. All experimental procedures and protocols were approved by the Laboratory Animal Ethics Committee of Jinan University, China (approval No. 20170228010) on February 28, 2017.
- 19 June 2020
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 15 (12) , 2335-2343
Open AccessInsulin-like growth factor 1 partially rescues early developmental defects caused by SHANK2 knockdown in human neurons
SHANK2 is a scaffold protein that serves as a protein anchor at the postsynaptic density in neurons. Genetic variants of SHANK2 are strongly associated with synaptic dysfunction and the pathophysiology of autism spectrum disorder. Recent studies indicate that early neuronal developmental defects play a role in the pathogenesis of autism spectrum disorder, and that insulin-like growth factor 1 has a positive effect on neurite development. To investigate the effects of SHANK2 knockdown on early neuronal development, we generated a sparse culture system using human induced pluripotent stem cells, which then differentiated into neural progenitor cells after 3–14 days in culture, and which were dissociated into single neurons. Neurons in the experimental group were infected with shSHANK2 lentivirus carrying a red fluorescent protein reporter (shSHANK2 group). Control neurons were infected with scrambled shControl lentivirus carrying a red fluorescent protein reporter (shControl group). Neuronal somata and neurites were reconstructed based on the lentiviral red fluorescent protein signal. Developmental dendritic and motility changes in VGLUT1 + glutamatergic neurons and TH + dopaminergic neurons were then evaluated in both groups. Compared with shControl VGLUT1 + neurons, the dendritic length and arborizations of shSHANK2 VGLUT1 + neurons were shorter and fewer, while cell soma speed was higher. Furthermore, dendritic length and arborization were significantly increased after insulin-like growth factor 1 treatment of shSHANK2 neurons, while cell soma speed remained unaffected. These results suggest that insulin-like growth factor 1 can rescue morphological defects, but not the change in neuronal motility. Collectively, our findings demonstrate that SHANK2 deficiency perturbs early neuronal development, and that IGF1 can partially rescue the neuronal defects caused by SHANK2 knockdown. All experimental procedures and protocols were approved by the Laboratory Animal Ethics Committee of Jinan University, China (approval No. 20170228010) on February 28, 2017.